BlackRock Capital Allocation Term Trust (NYSE:BCAT – Get Free Report) was the target of a significant decline in short interest in November. As of November 30th, there was short interest totalling 113,400 shares, a decline of 54.9% from the November 15th total of 251,200 shares. Based on an average trading volume of 369,600 shares, the short-interest ratio is presently 0.3 days.
Insider Activity at BlackRock Capital Allocation Term Trust
In other news, major shareholder Saba Capital Management, L.P. sold 14,973 shares of the stock in a transaction on Thursday, September 19th. The stock was sold at an average price of $16.41, for a total value of $245,706.93. Following the sale, the insider now directly owns 16,302,733 shares of the company’s stock, valued at approximately $267,527,848.53. This represents a 0.09 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders have sold a total of 723,927 shares of company stock worth $11,925,047 over the last quarter.
Institutional Investors Weigh In On BlackRock Capital Allocation Term Trust
Several institutional investors and hedge funds have recently added to or reduced their stakes in BCAT. Ashton Thomas Securities LLC purchased a new position in shares of BlackRock Capital Allocation Term Trust in the third quarter worth approximately $156,000. Walleye Capital LLC purchased a new position in shares of BlackRock Capital Allocation Term Trust during the 3rd quarter worth $234,000. B. Riley Wealth Advisors Inc. bought a new stake in shares of BlackRock Capital Allocation Term Trust during the 3rd quarter valued at $238,000. Truist Financial Corp purchased a new stake in shares of BlackRock Capital Allocation Term Trust in the 2nd quarter worth $319,000. Finally, Prospera Financial Services Inc raised its holdings in BlackRock Capital Allocation Term Trust by 5.0% in the 3rd quarter. Prospera Financial Services Inc now owns 23,693 shares of the company’s stock worth $390,000 after purchasing an additional 1,137 shares during the period. Hedge funds and other institutional investors own 36.12% of the company’s stock.
BlackRock Capital Allocation Term Trust Stock Up 0.1 %
BlackRock Capital Allocation Term Trust Increases Dividend
The business also recently disclosed a monthly dividend, which will be paid on Monday, December 23rd. Stockholders of record on Monday, December 16th will be issued a dividend of $0.2892 per share. This represents a $3.47 annualized dividend and a dividend yield of 21.26%. This is a boost from BlackRock Capital Allocation Term Trust’s previous monthly dividend of $0.10. The ex-dividend date of this dividend is Monday, December 16th.
About BlackRock Capital Allocation Term Trust
–
Read More
- Five stocks we like better than BlackRock Capital Allocation Term Trust
- The 3 Best Blue-Chip Stocks to Buy Now
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Which Wall Street Analysts are the Most Accurate?
- Texas Instruments: The Old-School Tech Titan Still Delivering
- What is a Death Cross in Stocks?
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.